Trial · NCT07908069
Efficacy, Satisfaction, And Safety Of Cellulite Treatment Using Collagen Biostimulators
NCT07908069, Not applicable, Completed, Antony Barbosa Institute
3 sourcestrials-2026-11-12-0.5.0
Cite this record
ConductScience Library. Efficacy, Satisfaction, And Safety Of Cellulite Treatment Using Collagen Biostimulators. Trials, record NCT07908069. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT07908069
On this page
Trial
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
- Title
- Efficacy, Satisfaction, And Safety Of Cellulite Treatment Using Collagen Biostimulators
- NCT number
- NCT07908069
- Status
- Completed
- Phases
- Not applicable
- Enrollment
- 30 participants, actual
- Lead sponsor
- Antony Barbosa Institute
- Conditions
- Cellulite
- Interventions
- Poly-L-Lactic Acid, Calcium Hydroxyapatite
- First posted
- 2026-10-30
- Last updated
- 2026-10-30
Source ClinicalTrials.gov
Registered outcomes1
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Change From Baseline in Cellulite Severity Scale Score at Day 30 | Baseline (Day 0) and Day 30 | Cellulite severity will be assessed using the Cellulite Severity Scale developed by Hexsel, Dal'Forno, and Hexsel. The scale assesses five clinical and morphological characteristics of cellulite, with each item scored from 0 to 3. The total score ranges from 0 to 15, with higher scores indicating greater cellulite severity and therefore a worse outcome. The change will be calculated as the total score at Day 30 minus the total score at baseline. Negative change values indicate a reduction in cellulite severity and therefore a better outcome. |
Source ClinicalTrials.gov
Outcomes0
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
None in this release.
Results by group0
Each measurement the trial posted, group by group, in the words and numbers it posted.
None in this release.
Participant flow0
How many started, completed or left each group, period by period.
None in this release.
Adverse events0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
None in this release.
Adverse event totals0
The totals the trial posted for each group.
None in this release.
Papers0
The papers the trial lists on ClinicalTrials.gov.
None in this release.
Grants0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
None in this release.
Trial comparisons0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
None in this release.
Tests0
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
None in this release.
Data dates
The day each source was copied for this release.
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this trial from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/trials/v1/NCT07908069
GET https://conductscience.org/api/trials/v1/NCT07908069/registered